|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
Statistics, 2017. CA Cancer J Clin. 67:7–30. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lee DH, Sung KS, Bartlett DL, Kwon YT and
Lee YJ: HSP90 inhibitor NVP-AUY922 enhances TRAIL-induced apoptosis
by suppressing the JAK2-STAT3-Mcl-1 signal transduction pathway in
colorectal cancer cells. Cell Signal. 27:293–305. 2015. View Article : Google Scholar
|
|
3
|
Vo MC, Nguyen-Pham TN, Lee HJ, Jaya
Lakshmi T, Yang S, Jung SH, Kim HJ and Lee JJ: Combination therapy
with dendritic cells and lenalidomide is an effective approach to
enhance antitumor immunity in a mouse colon cancer model.
Oncotarget. 8:27252–27262. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hail N Jr, Carter BZ, Konopleva M and
Andreeff M: Apoptosis effector mechanisms: a requiem performed in
different keys. Apoptosis. 11:889–904. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kirkin V, Joos S and Zörnig M: The role of
Bcl-2 family members in tumorigenesis. Biochim Biophys Acta.
1644:229–249. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Danial NN and Korsmeyer SJ: Cell death:
Critical control points. Cell. 116:205–219. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
McDonnell TJ, Troncoso P, Brisbay SM,
Logothetis C, Chung LW, Hsieh JT, Tu SM and Campbell ML: Expression
of the protooncogene bcl-2 in the prostate and its association with
emergence of androgen-independent prostate cancer. Cancer Res.
52:6940–6944. 1992.PubMed/NCBI
|
|
8
|
Teixeira C, Reed JC and Pratt MA: Estrogen
promotes chemotherapeutic drug resistance by a mechanism involving
Bcl-2 proto-oncogene expression in human breast cancer cells.
Cancer Res. 55:3902–3907. 1995.PubMed/NCBI
|
|
9
|
Peddaboina C, Jupiter D, Fletcher S, Yap
JL, Rai A, Tobin RP, Jiang W, Rascoe P, Rogers MK, Smythe WR, et
al: The down-regulation of Mcl-1 via USP9X inhibition sensitizes
solid tumors to Bcl-xl inhibition. BMC Cancer. 12:5412012.
View Article : Google Scholar
|
|
10
|
Takahashi H, Chen MC, Pham H, Angst E,
King JC, Park J, Brovman EY, Ishiguro H, Harris DM, Reber HA, et
al: Baicalein, a component of Scutellaria baicalensis, induces
apoptosis by Mcl-1 down-regulation in human pancreatic cancer
cells. Biochim Biophys Acta. 1813:1465–1474. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Patel D, Shukla S and Gupta S: Apigenin
and cancer chemoprevention: Progress, potential and promise
(Review). Int J Oncol. 30:233–245. 2007.
|
|
12
|
Shukla S and Gupta S: Apigenin: A
promising molecule for cancer prevention. Pharm Res. 27:962–978.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Shao H, Jing K, Mahmoud E, Huang H, Fang X
and Yu C: Apigenin sensitizes colon cancer cells to antitumor
activity of ABT-263. Mol Cancer Ther. 12:2640–2650. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Turkson J and Jove R: STAT proteins: Novel
molecular targets for cancer drug discovery. Oncogene.
19:6613–6626. 2000. View Article : Google Scholar
|
|
15
|
Bowman T, Garcia R, Turkson J and Jove R:
STATs in oncogenesis. Oncogene. 19:2474–2488. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Xiong H, Su WY, Liang QC, Zhang ZG, Chen
HM, Du W, Chen YX and Fang JY: Inhibition of STAT5 induces G1 cell
cycle arrest and reduces tumor cell invasion in human colorectal
cancer cells. Lab Invest. 89:717–725. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Donato NJ, Wu JY, Zhang L, Kantarjian H
and Talpaz M: Down-regulation of
interleukin-3/granulocyte-macrophage colony-stimulating factor
receptor beta-chain in BCR-ABL(+) human leukemic cells: Association
with loss of cytokine-mediated Stat-5 activation and protection
from apoptosis after BCR-ABL inhibition. Blood. 97:2846–2853. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Garcia R, Bowman TL, Niu G, Yu H, Minton
S, Muro-Cacho CA, Cox CE, Falcone R, Fairclough R, Parsons S, et
al: Constitutive activation of Stat3 by the Src and JAK tyrosine
kinases participates in growth regulation of human breast carcinoma
cells. Oncogene. 20:2499–2513. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Seo HS, Ku JM, Choi HS, Woo JK, Jang BH,
Go H, Shin YC and Ko SG: Apigenin induces caspase-dependent
apoptosis by inhibiting signal transducer and activator of
transcription 3 signaling in HER2-overexpressing SKBR3 breast
cancer cells. Mol Med Rep. 12:2977–2984. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Cao HH, Chu JH, Kwan HY, Su T, Yu H, Cheng
CY, Fu XQ, Guo H, Li T, Tse AK, et al: Inhibition of the STAT3
signaling pathway contributes to apigenin-mediated anti-metastatic
effect in melanoma. Sci Rep. 6:217312016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tomita S, Yamauchi M, Ichikawa K, Mitomi H
and Fujimori T: The brand new trend of colorectal carcinoma
pathology. Nihon Rinsho. 72:63–70. 2014.In Japanese. PubMed/NCBI
|
|
22
|
Wang SW and Sun YM: The IL-6/JAK/STAT3
pathway: Potential therapeutic strategies in treating colorectal
cancer (Review). Int J Oncol. 44:1032–1040. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Gupta S, Afaq F and Mukhtar H: Selective
growth-inhibitory, cell-cycle deregulatory and apoptotic response
of apigenin in normal versus human prostate carcinoma cells.
Biochem Biophys Res Commun. 287:914–920. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Turktekin M, Konac E, Onen HI, Alp E,
Yilmaz A and Menevse S: Evaluation of the effects of the flavonoid
apigenin on apoptotic pathway gene expression on the colon cancer
cell line (HT29). J Med Food. 14:1107–1117. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Horinaka M, Yoshida T, Shiraishi T, Nakata
S, Wakada M and Sakai T: The dietary flavonoid apigenin sensitizes
malignant tumor cells to tumor necrosis factor-related
apoptosis-inducing ligand. Mol Cancer Ther. 5:945–951. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lee Y, Sung B, Kang YJ, Kim DH, Jang JY,
Hwang SY, Kim M, Lim HS, Yoon JH, Chung HY, et al: Apigenin-induced
apoptosis is enhanced by inhibition of autophagy formation in
HCT116 human colon cancer cells. Int J Oncol. 44:1599–1606. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Budhraja A, Gao N, Zhang Z, Son YO, Cheng
S, Wang X, Ding S, Hitron A, Chen G, Luo J, et al: Apigenin induces
apoptosis in human leukemia cells and exhibits anti-leukemic
activity in vivo. Mol Cancer Ther. 11:132–142. 2012. View Article : Google Scholar
|
|
28
|
Lu HF, Chie YJ, Yang MS, Lee CS, Fu JJ,
Yang JS, Tan TW, Wu SH, Ma YS, Ip SW, et al: Apigenin induces
caspase-dependent apoptosis in human lung cancer A549 cells through
Bax- and Bcl-2-triggered mitochondrial pathway. Int J Oncol.
36:1477–1484. 2010.PubMed/NCBI
|
|
29
|
Shi MD, Shiao CK, Lee YC and Shih YW:
Apigenin, a dietary flavonoid, inhibits proliferation of human
bladder cancer T-24 cells via blocking cell cycle progression and
inducing apoptosis. Cancer Cell Int. 15:332015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhao M, Ma J, Zhu HY, Zhang XH, Du ZY, Xu
YJ and Yu XD: Apigenin inhibits proliferation and induces apoptosis
in human multiple myeloma cells through targeting the trinity of
CK2, Cdc37 and Hsp90. Mol Cancer. 10:1042011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Brunelle JK and Letai A: Control of
mitochondrial apoptosis by the Bcl-2 family. J Cell Sci.
122:437–441. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kelly PN and Strasser A: The role of Bcl-2
and its pro-survival relatives in tumourigenesis and cancer
therapy. Cell Death Differ. 18:1414–1424. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Czabotar PE, Lessene G, Strasser A and
Adams JM: Control of apoptosis by the BCL-2 protein family:
Implications for physiology and therapy. Nat Rev Mol Cell Biol.
15:49–63. 2014. View Article : Google Scholar
|
|
34
|
Brotin E, Meryet-Figuière M, Simonin K,
Duval RE, Villedieu M, Leroy-Dudal J, Saison-Behmoaras E, Gauduchon
P, Denoyelle C and Poulain L: Bcl-XL and MCL-1 constitute pertinent
targets in ovarian carcinoma and their concomitant inhibition is
sufficient to induce apoptosis. Int J Cancer. 126:885–895.
2010.
|
|
35
|
Varin E, Denoyelle C, Brotin E,
Meryet-Figuière M, Giffard F, Abeilard E, Goux D, Gauduchon P,
Icard P and Poulain L: Downregulation of Bcl-xL and Mcl-1 is
sufficient to induce cell death in mesothelioma cells highly
refractory to conventional chemotherapy. Carcinogenesis.
31:984–993. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Takahashi H, Chen MC, Pham H, Matsuo Y,
Ishiguro H, Reber HA, Takeyama H, Hines OJ and Eibl G: Simultaneous
knock-down of Bcl-xL and Mcl-1 induces apoptosis through Bax
activation in pancreatic cancer cells. Biochim Biophys Acta.
1833:2980–2987. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Buettner R, Mora LB and Jove R: Activated
STAT signaling in human tumors provides novel molecular targets for
therapeutic intervention. Clin Cancer Res. 8:945–954.
2002.PubMed/NCBI
|
|
38
|
Sueda T, Sakai D, Kawamoto K, Konno M,
Nishida N, Koseki J, Colvin H, Takahashi H, Haraguchi N, Nishimura
J, et al: BRAF V600E inhibition stimulates AMP-activated protein
kinase-mediated autophagy in colorectal cancer cells. Sci Rep.
6:189492016. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Shan S, Shi J, Yang P, Jia B, Wu H, Zhang
X and Li Z: Apigenin restrains colon cancer cell proliferation via
targeted blocking of pyruvate kinase M2-dependent glycolysis. J
Agric Food Chem. 65:8136–8144. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
McVean M, Weinberg WC and Pelling JCA: A
p21(waf1)-independent pathway for inhibitory phosphorylation of
cyclin-dependent kinase p34(cdc2) and concomitant G(2)/M arrest by
the chemopreventive flavonoid apigenin. Mol Carcinog. 33:36–43.
2002. View Article : Google Scholar : PubMed/NCBI
|
